A detailed history of Virginia Retirement Systems Et Al transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 30,900 shares of BPMC stock, worth $2.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
30,900
Previous 25,900 19.31%
Holding current value
$2.8 Million
Previous $1.64 Million 5.2%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jan 02, 2024

BUY
$46.9 - $66.0 $234,500 - $330,000
5,000 Added 19.31%
30,900 $1.55 Million
Q2 2023

Aug 22, 2023

BUY
$42.2 - $66.37 $101,280 - $159,288
2,400 Added 10.21%
25,900 $1.64 Million
Q1 2023

Jul 11, 2023

BUY
$37.97 - $50.0 $60,752 - $80,000
1,600 Added 7.31%
23,500 $1.06 Million
Q4 2022

May 17, 2023

BUY
$41.06 - $66.48 $201,194 - $325,752
4,900 Added 28.82%
21,900 $959 Million
Q3 2022

May 16, 2023

BUY
$49.93 - $77.7 $59,916 - $93,240
1,200 Added 7.59%
17,000 $1.12 Billion
Q1 2022

Apr 21, 2022

BUY
$54.1 - $110.08 $32,460 - $66,048
600 Added 3.95%
15,800 $1.01 Million
Q4 2021

Feb 03, 2022

SELL
$94.25 - $115.99 $1.07 Million - $1.32 Million
-11,400 Reduced 42.86%
15,200 $1.63 Million
Q3 2021

Oct 21, 2021

SELL
$80.98 - $109.47 $396,802 - $536,403
-4,900 Reduced 15.56%
26,600 $2.74 Million
Q2 2021

Aug 13, 2021

BUY
$82.78 - $101.0 $430,456 - $525,200
5,200 Added 19.77%
31,500 $2.77 Million
Q1 2021

Apr 30, 2021

BUY
$90.71 - $108.28 $879,886 - $1.05 Million
9,700 Added 58.43%
26,300 $2.56 Million
Q4 2020

Feb 16, 2021

BUY
$92.08 - $124.48 $359,112 - $485,472
3,900 Added 30.71%
16,600 $1.86 Million
Q3 2020

Nov 12, 2020

BUY
$66.45 - $92.7 $511,665 - $713,790
7,700 Added 154.0%
12,700 $1.18 Million
Q2 2020

Aug 12, 2020

BUY
$57.09 - $79.27 $285,450 - $396,350
5,000 New
5,000 $390,000
Q1 2020

May 12, 2020

SELL
$48.11 - $82.22 $432,990 - $739,980
-9,000 Closed
0 $0
Q4 2019

Jan 27, 2020

BUY
$66.73 - $82.59 $600,570 - $743,310
9,000 New
9,000 $721,000

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.